Clinical Research Directory
Browse clinical research sites, groups, and studies.
PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
A multicenter international prospective observational pharmacological study in adult patients (≥18 years) treated with ceftazidime/avibactam (CAZ/AVI) alone or with CAZ/AVI plus fosfomycin (FOS) for infection due to carbapenem-resistant Enterobacterales (CRE) (KPC and/or OXA-48).
Official title: PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to Carbapenem-resistant Enterobacterales (CRE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2023-12-01
Completion Date
2026-04-30
Last Updated
2025-11-28
Healthy Volunteers
No
Locations (2)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy
Instituto de Biomedicina de Sevilla (IBiS), Hospital Virgen Macarena/CSIC/Universidad de Sevilla
Seville, Seville, Spain